Bayesian Capital Management, LP Pro Qr Therapeutics N.V. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.74 - $0.89 $148 - $178
200 Added 1.52%
13,400 $10,000
Q2 2022

Aug 15, 2022
SELL
$0.56 - $1.0 $224 - $400
-400 Reduced 2.94%
13,200 $10,000
Q1 2022

May 16, 2022
BUY
$0.9 - $8.39 $12,240 - $114,104
13,600 New
13,600 $12,000

Others Institutions Holding PRQR

# of Institutions
52
Shares Held
17.4M
Call Options Held
37.7K
Put Options Held
21.3K
View Full List

About ProQR Therapeutics N.V.

PRQR Quotes by TradingView
  • Ticker PRQR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,362,096
  • Market Cap $191M
  • Description
  • ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...
More about PRQR
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email